Cell News and Research

RSS

Neoadjuvant nivolumab treatment improves survival rates in NSCLC patients

Patients with resectable non-small cell lung cancer (NSCLC) who were treated with neoadjuvant nivolumab had improved five-year recurrence-free and overall survival rates compared with historical outcomes.

15 Feb 2023

Researchers identify a novel mechanism of DNA repair that occurs in neurons

"Use it or lose it" goes the adage, applied liberally to everything from our muscles to our minds, especially as we age.

15 Feb 2023

Computational modeling helps uncover genomic mutations that likely influenced human cognition

Researchers from the National Institutes of Health (NIH) used computational modeling to uncover mutations in the human genome that likely influenced the evolution of human cognition.

15 Feb 2023

Three new language versions of the 'Together by St. Jude' online resource launched

St. Jude Children's Research Hospital today announced the launch of three new language versions of the Together by St. Jude online resource, a free source of information and education for families facing childhood and adolescent cancer.

15 Feb 2023

B lymphocytes play a pivotal role in promoting an emergent response during infection

An SOS signals a call for immediate action during an emergency to request a need for protection. The immune system, a network of defense mechanisms, enhances protection to recover the body's internal stability.

15 Feb 2023

Scientific breakthrough by Sjöberg laureate brings new hope to lung cancer patients

This year's Sjöberg Prize in cancer research of one million dollars is awarded to professor Kevan Shokat, University of California, USA.

15 Feb 2023

Promising HIV vaccine candidate by Texas Biomed stops the virus upon entry

The National Institutes of Health has awarded $3.8 million to Texas Biomedical Research Institute to further develop a promising HIV vaccine candidate that stops the virus upon entry, before it begins rapidly spreading throughout the body.

15 Feb 2023

NIH initiates a clinical trial evaluating an investigational antiviral for treatment of COVID-19

The National Institutes of Health has initiated a multi-site clinical trial evaluating an investigational antiviral for the treatment of COVID-19.

15 Feb 2023

Scientists reach a substantial consensus on the four principles that will enable the future development and expansion of virus taxonomy

A team of 45 virologists, evolutionary biologists, bioinformaticians, and structural biologists from around the world arrived at a consensus on virus classification methodologies and presented an integrated taxonomical framework for the systematics and taxonomy of viruses.

15 Feb 2023

Meet Fujifilm Europe at ECR 2023

Join Fujifilm Europe in Vienna, Austria, for new product launches, an MRI symposium, and a chance to meet our experts and learn how we can take on the healthcare challenge together.

From FUJIFILM Corporation 15 Feb 2023

DeNovix celebrates sustainability award with Green CellDrop™ Automated Cell Counter Giveaway

DeNovix Inc. is giving away a Green CellDrop™ Automated Cell Counter to celebrate the instrument’s new Sustainable Laboratory Product of the Year award from SelectScience.

From DeNovix Inc. 15 Feb 2023

Study finds a new mammalian antiviral response pathway restricting poxviruses replication

In a recent study posted to the bioRxiv* preprint server, researchers identified a novel antiviral pathway different from the interferon (IFN) pathway that inhibited poxvirus(es) replication.

15 Feb 2023

Cocaine use disorder leads to changes in the 'methylome' of a brain region

Scientists tend to view substance addiction as primarily a disease of the brain. When we enjoy sex, food, music, or hobbies, regions of our brain within the reward pathway are flooded with pleasure-inducing dopamine.

14 Feb 2023

Study reveals how astrocytes of socially-isolated mice cause learning and memory deficits

Here is an important reason to stay in touch with friends and family: social isolation causes memory and learning deficits and other behavioral changes.

14 Feb 2023

New insights into the role of T-cells during long COVID

Researchers characterize the trajectory of long COVID in patients eight months after recovering from infection.

14 Feb 2023

Study indicates that ultra-processed foods are linked to depression

The current paper, published in the journal Nutrients, looks at UPFs in relation to depressive symptoms in a group of younger Italian adults.

14 Feb 2023

Alternate-day fasting diet and exercise benefit the health of people with nonalcoholic fatty liver disease

Nutrition researchers at the University of Illinois Chicago studied 80 people with nonalcoholic fatty liver disease and found that those who followed an alternate-day fasting diet and exercised were able to improve their health.

14 Feb 2023

Study could lead to a safe, on-demand and reversible oral contraceptive for men

In a mouse study, researchers funded by the National Institutes of Health have identified a potential non-hormonal contraceptive that men could take shortly before sexual activity and have fertility restored the next day.

14 Feb 2023

Cabometyx® in combination with nivolumab shows durable survival benefits at over three-years’ follow-up in first-line advanced renal cell carcinoma

Ipsen (Euronext: IPN; ADR: IPSEY) today announced three-year minimum, 44-month median, follow-up results from the Phase III CheckMate -9ER trial showing that Cabometyx® (cabozantinib) in combination with nivolumab provides survival and response rate benefits after three-years in the first-line treatment of advanced renal cell carcinoma (aRCC), compared to sunitinib.

From Ipsen 14 Feb 2023

Complete genomics drops genome sequencing price to sub $100 at AGBT General Meetin

Complete Genomics Inc., a global life science tools leader and subsidiary of MGI Tech Co., Ltd. (“MGI”), today launched new revolutionary products and prices at Advances in Genome Biology and Technology (AGBT) General Meeting.

From MGI 14 Feb 2023

Cell News and Research

Neoadjuvant nivolumab treatment improves survival rates in NSCLC patients

Researchers identify a novel mechanism of DNA repair that occurs in neurons

Computational modeling helps uncover genomic mutations that likely influenced human cognition

Three new language versions of the 'Together by St. Jude' online resource launched

B lymphocytes play a pivotal role in promoting an emergent response during infection

Scientific breakthrough by Sjöberg laureate brings new hope to lung cancer patients

Promising HIV vaccine candidate by Texas Biomed stops the virus upon entry

NIH initiates a clinical trial evaluating an investigational antiviral for treatment of COVID-19

Scientists reach a substantial consensus on the four principles that will enable the future development and expansion of virus taxonomy

Meet Fujifilm Europe at ECR 2023

DeNovix celebrates sustainability award with Green CellDrop™ Automated Cell Counter Giveaway

Study finds a new mammalian antiviral response pathway restricting poxviruses replication

Cocaine use disorder leads to changes in the 'methylome' of a brain region

Study reveals how astrocytes of socially-isolated mice cause learning and memory deficits

New insights into the role of T-cells during long COVID

Study indicates that ultra-processed foods are linked to depression

Alternate-day fasting diet and exercise benefit the health of people with nonalcoholic fatty liver disease

Study could lead to a safe, on-demand and reversible oral contraceptive for men

Cabometyx® in combination with nivolumab shows durable survival benefits at over three-years’ follow-up in first-line advanced renal cell carcinoma

Complete genomics drops genome sequencing price to sub $100 at AGBT General Meetin

Improve fermentation and cell culture performance with real-time gas analysis eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo